- Home
- » Tags
- » Colestyramine
Top View
- Cardiovascular System
- Review of Existing Classification Efforts
- EZETROL 10Mg Tablets Leaflet 01-12-14-1 1081 Crestor
- Trends in Lipid-Modifying Agent Use in 83 Countries
- FAMILIAL HYPERCHOLESTEROLAEMIA (Based on NICE Clinical Guideline 71, Last Updated Oct 2019)
- Drug Class Review on HMG-Coa Reductase Inhibitors (Statins)
- V010 Package Leaflet: Information for the Patient Ezetimibe/Simvastatin 10 Mg/10 Mg, 10 Mg/20 Mg, 10 Mg/40 Mg, 10 Mg/80 Mg Table
- PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
- Evolving Worldwide Approaches to Lipid Management and Implications for Australian General Practice
- Package Leaflet: Information for the User Rosuvastatin/Ezetimibe Abbott 10 Mg / 10 Mg Film-Coated Tablets Rosuvastatin/Ezetimibe
- QUESTRAN LITE Colestyramine Powder for Oral Solution
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Australian Statistics on Medicines 2009
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
- Download NUSTENDI ® Patient Brochure
- 01 Stockley's Herbal Medicines Interactions PRELIMS 1
- Guidelines for ATC Classification and DDD Assignment 2021
- Bile Acid Malabsorption Information
- Crohn's Disease – Adalimumab for Patients Refractory to Inflximab
- Package Leaflet
- Statines in België: Evolutie in Het Gebruik En Invloed Van Het Terugbetalingsbeleid
- The Impact of Obesity on the Efficacy of Simvastatin for Lowering Low-Density Lipoprotein Cholesterol in a Veteran Population
- Cholestagel, INN-Colesevelam
- Guidelines for ATC Classification and DDD Assignment 2013
- Download Report Appendixes [PDF · 3.8
- Package Leaflet: Information for the User [Name Completed Nationally] 10 Mg Tablets, Ezetimibe Read All of This Leaflet Carefull
- Gastroenterology
- 'Essays in Regulation of Pharmaceutical Markets'
- The Role of Bile Acid Sequestrant in Diarrhea Management: Too Good to Be True? Helen Senderovich1,* and Ehsan Ghassem Khani2
- Application of WHO ATC/ DDD Methods in Medicine Utilisation Research: a Hands-On Experience Ilse Truter 2019
- Draft Comparative Effectiveness Review
- Pravafenix, INN-Pravastatin/Fenofibrate
- EZALO COMPOSITE PACK Ezetimibe and Rosuvastatin Calcium
- Study Protocol 1002-047 Amendment 3, 09 May 2017
- Nilemdo, INN-Bempedoic Acid
- In 2003, the MOPH Published a First National Essential Drug List (EDL)
- Drug Class Review on HMG-Coa Reductase Inhibitors (Statins)
- (SJAMS) Familial Dyslipidemia
- Resolution Ap (2000) 1
- Randomised Clinical Trial: Colestyramine Vs
- Nustendi, INN-Bempedoic Acid/Ezetimibe
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Simvastatin 10 Mg Film-Coated Tablets Simvastatin 20 Mg Film-Coated Tablets Simvastatin 40 Mg Film-Coated Tablets Simvastatin
- Comparative Analysis of the Use of Lipid Modifying Agents in the Republic of Serbia and Nordic Countries in the Period 2015-2017
- PHARMACY Medications to Treat High Cholesterol and Triglycerides
- Emerging Antidyslipidemic Drugs
- The Effect of Early, Intensive Statin Therapy on Acute Coronary Syndrome a Meta-Analysis of Randomized Controlled Trials
- Shortage of Bile Acid Sequestrants – Colestyramine Powder for Oral Suspension 4G (Questran) and Colestipol (Colestid)
- Tredaptive, INN-Nicotinic Acid/Laropiprant